Company Registration No. 12747694 (England and Wales)
Biotech Research Laboratories Limited
Unaudited accounts
for the year ended 5 April 2024
Biotech Research Laboratories Limited
Statement of financial position
as at 5 April 2024
Intangible assets
7,423
9,279
Tangible assets
179,895
268,502
Cash at bank and in hand
11,098
10,253
Creditors: amounts falling due within one year
(368,143)
(446,618)
Net current liabilities
(314,329)
(366,736)
Net liabilities
(127,011)
(88,955)
Called up share capital
100
100
Profit and loss account
(127,111)
(89,055)
Shareholders' funds
(127,011)
(88,955)
For the year ending 5 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 26 March 2025 and were signed on its behalf by
Thomas Meany
Director
Company Registration No. 12747694
Biotech Research Laboratories Limited
Notes to the Accounts
for the year ended 5 April 2024
Biotech Research Laboratories Limited is a private company, limited by shares, registered in England and Wales, registration number 12747694. The registered office is Peachey & Co Llp, 95 Aldwych, London, WC2B 4JF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Other
Biotech Research Laboratories Limited
Notes to the Accounts
for the year ended 5 April 2024
5
Tangible fixed assets
Plant & machinery
Computer equipment
Total
Cost or valuation
At cost
At cost
At 6 April 2023
258,567
9,935
268,502
At 5 April 2024
258,567
9,935
268,502
Charge for the year
85,328
3,279
88,607
At 5 April 2024
85,328
3,279
88,607
At 5 April 2024
173,239
6,656
179,895
At 5 April 2023
258,567
9,935
268,502
Amounts falling due within one year
Accrued income and prepayments
42,716
68,865
7
Creditors: amounts falling due within one year
2024
2023
Trade creditors
7,950
7,950
Taxes and social security
-
(166,271)
Loans from directors
358,162
595,900
8
Average number of employees
During the year the average number of employees was 2 (2023: 6).